So. NWBO looks like it has a successful trial that suggests they also have a tumor agnostic immunotherapy that is easy to accept, has virtually no side-effects and could have a very high survival and possibly “cure” rate when used in combination with or with adjuvants.
NVCR has a treatment that the UK and some US states find reason to doubt is even worth providing.
News 
Market Data 
Discover 
